OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
39
Results
Show all
Save search
Copy query
Show results for
Unknown
(39)
Publication Date
Release Date
2022
(8)
2021
(7)
2018
(6)
2024
(5)
2020
(3)
2019
(3)
2025
(2)
2023
(2)
2017
(1)
2016
(1)
2006
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
COVID-19 patients and Dementia: Frontal cortex transcriptomic data.
Not available
S-EPMC8479506
|
biostudies-literature
Cite
COVID-19-related neuropathology and microglial activation in elderly with and without dementia.
Not available
S-EPMC8412067
|
biostudies-literature
Cite
The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
Not available
S-EPMC8902152
|
biostudies-literature
Cite
Inflammation and cell-to-cell communication, two related aspects in frailty.
Not available
S-EPMC9598012
|
biostudies-literature
Cite
Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach.
Not available
S-EPMC7247337
|
biostudies-literature
Cite
Homocysteine, Folic Acid, Cyanocobalamin, and Frailty in Older People: Findings From the "Invece. Ab" Study.
Not available
S-EPMC8717775
|
biostudies-literature
Cite
New CACNA1A deletions are associated to migraine phenotypes.
Not available
S-EPMC6117225
|
biostudies-literature
Cite
Patients' Stem Cells Differentiation in a 3D Environment as a Promising Experimental Tool for the Study of Amyotrophic Lateral Sclerosis.
Not available
S-EPMC9141644
|
biostudies-literature
Cite
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases.
Not available
S-EPMC10931808
|
biostudies-literature
Cite
Impact of SOD1 Transcript Variants on Amyotrophic Lateral Sclerosis Severity
Not available
S-EPMC12295590
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets